FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology, specifically to obtaining a pegylated recombinant consensus interferon version conjugate, and can be used in medicine. The invention enables to obtain an interferon-based anti-HBV drug, in which the activated PEG molecule is linked through a short linker to the α-amino group of glycine at the N-end of the recombinant consensus interferon version.
EFFECT: invention enables to obtain an anti-HBV drug with high water solubility and low toxicity and immunogenicity compared to a natural interferon.
3 cl, 6 dwg, 12 ex
Title |
Year |
Author |
Number |
PEG-MODIFIED HUMAN INTERFERON β-1a MOLECULE WITH ANTIVIRAL, IMMUNOMODULATORY AND ANTIPROLIFERATIVE ACTIVITY, WITH IMPROVED STABILITY, REDUCED IMMUNOGENICITY, IMPROVED PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS, SUITABLE FOR MEDICAL USE, AND IMMUNOBIOLOGICAL FORMULATION BASED THEREON |
2013 |
- Chernovskaja Tat'Jana Veniaminovna
- Efanov Jurij Georgievich
- Morozov Dmitrij Valentinovich
- Rudenko Elena Georgievna
- Korzhavin Dmitrij Valer'Evich
- Ustjugov Jakov Jur'Evich
- Ivanov Roman Alekseevich
|
RU2576372C2 |
NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON |
2010 |
- Chernovskaja Tat'Jana Veniaminovna
- Denisov Lev Aleksandrovich
- Morozov Dmitrij Valentinovich
- Rudenko Elena Georgievna
- Klenova Angelina Vsevolodovna
|
RU2447083C1 |
INTERFERON CONJUGATES AND METHOD FOR PRODUCTION THEREOF |
2011 |
- Nekrasov Arkadij Vasil'Evich
- Skrypin Vasilij Ivanovich
- Puchkova Natal'Ja Grigor'Evna
- Medvedev Sergej Alekseevich
|
RU2466138C1 |
POLYETHYLENE GLYCOL MODIFIED INTERFERON ALPHA 2B, PRODUCING AND USING PREPARATION |
2007 |
- Tskhou Vajdong
- Ksiao Kvingdzhiang
- Sun Li
- Vang Tibing
- Jin Fengkhong
- Luo Shikhong
- Shuang Lu
- Liu Min
- Ksu Tianle
- Shang Jong
|
RU2485134C2 |
PREVENTIVE OR THERAPEUTIC AGENT AGAINST VIRAL DISEASE |
2007 |
- Khiasa Joiti
- Kuzukhara Khirojuki
|
RU2433827C2 |
LIQUID COMPOSITION OF LONG-ACTING ALPHA INTERFERON CONJUGATE |
2011 |
- Im Dae Seong
- Li Dzae Min
- Li Dzong Soo
- Bae Sung Min
- Kvon Se Chang
|
RU2613905C2 |
SINGLE NUCLEOTIDE POLYMORPHISM ON CHROMOSOME 15 ENABLING PREDICTION OF HCV TREATMENT RESPONSES |
2012 |
- Benejd Rima
- Essyu Loran
- Navarro Mersidita T.
- Palermo Dzhuzeppe
- Rili-Gillis Bridzhit
- Chzhu Yunkhun
|
RU2606759C2 |
COMPLEX FOR ENHANCING IMMUNE RESPONSE |
2019 |
- Lin, Haixiang
- Liu, Fang
- Zha, Li
|
RU2779622C2 |
PROTEIN SHOWING INTERFERON-LIKE ANTIVIRAL AND ANTIPROLIFERATIVE BIOLOGICAL ACTIVITIES (VERSIONS), PROTEIN STRUCTURE, CODING POLYNUCLEOTIDE (VERSIONS), EXPRESSION VECTOR, HOST CELL, COMPOSITION AND USE OF PROTEIN AS ANTIVIRAL, ANTIPROLIFERATIVE, ANTICANCER OR IMMUNOMODULATORY AGENT AND METHOD OF TREATING CONDITION SENSITIVE TO INTERFERON-THERAPY, CANCER OR VIRAL DISEASE |
2007 |
- Van Khajtao
- Mao Chunshen
- Li Tszichzhi
- Van Lin
- Du Jun
- Lju Lunbin'
- Sjuj Tszin
- Chzhan Zhuj
|
RU2469091C2 |
METHOD OF SYNTHESISING CONJUGATES OF GLYCOSEAMINOGLYCANES (GAG) WITH BIOLOGICALLY ACTIVE MOLECULES, POLYMER CONJUGATES AND THEIR RESPECTIVE APPLICATIONS |
2010 |
- D'Ehste Matteo
- Ren'Er Davide
- Pazut Dzhanfranko
- Rozato Antonio
|
RU2530649C2 |